Category Archives: Investment

Health-sector IPO action picks up where 2019 left off with new SEC filings signaling high hopes for cash still parked on the sidelines.

Despite clashes over trade sanctions pending resolution with China and threats of war with Iran escalating to nerve-wracking heights, confidence in the US market for health-sector initial public offerings apparently… Read more »

Biotech IPO scene shifts into pre-holiday slow gear, but several former IPOs are soaring with analysts saying Buy, Buy, Buy!

IPO Sector: US tech IPOs have mostly vanished in the fourth quarter following disappointments from multiple fast-growing, unprofitable unicorns. Healthcare (55% of 4Q IPOs) and Chinese issuers (24%) have hogged… Read more »

Healthcare stocks forge ahead despite trade-wars jitters; but that makes sense if you think about it.

Currently considered a “hedge” against the US-China trade clashes, which don’t bear directly on the provision of healthcare here in the US, here are the three top winners and a… Read more »

US stock market has a subdued Thanksgiving week, but a slew of healthcare companies rocketed higher.

Here’s the blistering action on the Nasdaq from last week, with four of the top gainers and one of the sorely downtrodden: ChemoCentryx Inc. (Nasdaq:CCXI) led advancing issues, skyrocketing 282%… Read more »

More Chinese medical companies choosing New York over Shanghai, Hong Kong for IPOs; but not always.

Three companies priced in New York last week–two biotechs and Chinese online real estate marketplace Shenzhen Fangdd Network Technology Co Ltd. (Nasdaq:DUO). The China-USA, free-floating trade anxieties aren’t dissuading the… Read more »

Health-sector IPO market cools off for Veterans Day breather; but pre-Thanksgiving deals ready to rock.

The IPO market for the health sector had a slow week for Veteran’s Day with just three small deals priced, registered and withdrawn. Five more industry-wide deals  are getting out… Read more »

Health-sector IPO market cools off this week after torrid start to November.

After a busy week in the IPO market for the week of November 4, just one biotech is scheduled to go public in the week ahead. NASH biotech 89bio Inc. plans… Read more »

Fasten your seatbelts, investors: Chinese health sector IPOs creeping onto Nasdaq in bigger numbers.

In a wild week of health-sector action in the IPO arena, three more Chinese funding seekers eschewed the Shanghai and Hong Kong markets, favoring the more robust Nasdaq the week… Read more »

Health-sector stocks shine, leading major indices to new records.

US equities finished a week of clashing tariff headlines on a high note, as investors tried to anticipate the next moves in the trade war with China. Ten-year Treasury yields… Read more »